(2R,3S,4R,5R)-4-(benzyloxy)-2-((benzyloxy)methyl)-5-(1,3-dioxoisoindolin-2-yl)-6-hydroxytetrahydro-2H-pyran-3-yl acetate

Catalog No. :
ACLTWJ932
CAS No. :
89067-90-3
Molecular Formula :
C30H29NO8
Molecular Weight :
531.56

IUPAC Name:(2R,3S,4R,5R)-4-(benzyloxy)-2-((benzyloxy)methyl)-5-(1,3-dioxoisoindolin-2-yl)-6-hydroxytetrahydro-2H-pyran-3-yl acetate

(2R,3S,4R,5R)-4-(benzyloxy)-2-((benzyloxy)methyl)-5-(1,3-dioxoisoindolin-2-yl)-6-hydroxytetrahydro-2H-pyran-3-yl acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$2430.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2R,3S,4R,5R)-4-(benzyloxy)-2-((benzyloxy)methyl)-5-(1,3-dioxoisoindolin-2-yl)-6-hydroxytetrahydro-2H-pyran-3-yl acetate
IUPAC Name(2R,3S,4R,5R)-4-(benzyloxy)-2-((benzyloxy)methyl)-5-(1,3-dioxoisoindolin-2-yl)-6-hydroxytetrahydro-2H-pyran-3-yl acetate
Molecular FormulaC30H29NO8
Molecular Weight531.56
SMILESCC(O[C@@H]1[C@@H](COCC2=CC=CC=C2)OC(O)[C@H](N(C(C3=C4C=CC=C3)=O)C4=O)[C@H]1OCC5=CC=CC=C5)=O
InChI KeyPEAZGOSZSCYFRX-ZRECQIAMSA-N
Synonymβ-D-Glucopyranose, 2-deoxy-2-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)-3,6-bis-O-(phenylmethyl)-, 4-acetate;4-O-acetyl-3,6-di-O-benzyl-2-deoxy-2-phthalimido-β-D-glucopyranose;(2R,3S,4R,5R)-4-(Benzyloxy)-2-((benzyloxy)methyl)-5-(1,3-dioxoisoindolin-2-YL)-6-hydroxytetrahydro-2H-pyran-3-YL acetate
CAS No.89067-90-3

Synthetic Route by SureRoute

1. ACLTWJ932 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLTWJ932 route product structure diagram
    ACLTWJ93289067-90-3
Inquiry

2. ACLTWJ932 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLTWJ932 route product structure diagram
    ACLTWJ93289067-90-3
Inquiry

Comments (0)